Showing results (1481-1490 of 2,025) with videos related to
Sort By:
Pageof 203
British Journal of Cancer|March 20, 2018
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trialMichael L Maitland, Sarina Piha-Paul, Gerald Falchook, et al.Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|May 24, 2025
Critical care nurses' responses to clinical scenarios involving cardiopulmonary resuscitation for deceased inpatients without a Do Not Resuscitate order: A cross-sectional studyHeidi Hoi Ying Hui, Joanne Cordina, Judeil Krlan Teus, et al.Cancer Chemotherapy and Pharmacology|June 28, 2018
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumorsAmikar Sehdev, Theodore Karrison, Yuanyuan Zha, et al.European Heart Journal|June 4, 2011
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic dataRianne M F van Schie, Judith A M Wessels, Saskia le Cessie, et al.Drug Metabolism and Drug Interactions|October 26, 2012
Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance doseRianne M F van Schie, Talitha I Verhoef, Saskia B Boejharat, et al.Journal of Diabetes and Its Complications|June 7, 2019
Microvascular and macrovascular complications in type 2 diabetes Ghanaian residents in Ghana and Europe: The RODAM studyCharles Hayfron-Benjamin, Bert-Jan van den Born, Anke H Maitland-van der Zee, et al.Journal of the American College of Cardiology|April 9, 2021
Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5Kathryn J Lindley, C Noel Bairey Merz, Anita W Asgar, et al.Clinical and Experimental Dermatology|June 7, 2017
Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptomsM van der Lee, A Arabkhazaeli, F C van Erp, et al.Frontiers in Immunology|March 16, 2026
A functional cell model using basophil activation test to study molecular mechanisms and biomarkers of response to omalizumab treatment in patients with asthmaBoris Gole, Larisa Goričan, Gregor Jezernik, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma PatientsLevi B Richards, Job J M H van Bragt, Reim Aarab, et al.Pageof 203